---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-042406"
form_type: "8-K"
ticker: "CLDI"
cik: "0001855485"
company_name: "Calidi Biotherapeutics, Inc."
filed_at: "2024-10-24T23:59:59+00:00"
generated_at: "2026-05-30T10:38:02.686991+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Calidi Biotherapeutics raises $2M in registered direct offering and private placement of warrants

## Summary
- Sold 2,050,000 shares at $1.00 per share in a registered direct offering.
- Concurrent private placement: Series E and F warrants to purchase up to 2,050,000 shares each at $1.13, exercisable after 6 months.
- Gross proceeds ~$2 million; net proceeds for working capital and clinical trials.
- Placement agent Ladenburg Thalmann receives 8% cash fee and warrants for 102,500 shares at $1.25.
- Lock-up agreements: Company 30 days, directors/officers 90 days from closing.

## SEC filing metadata
- accession: 0001493152-24-042406
- form_type: 8-K
- ticker: CLDI
- cik: 0001855485
- company_name: Calidi Biotherapeutics, Inc.
- filed_at: 2024-10-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855485/000149315224042406/0001493152-24-042406-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855485/000149315224042406/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-042406
- JSON: https://secwatch.observer/filing/0001493152-24-042406.json
- Plain text: https://secwatch.observer/filing/0001493152-24-042406.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.